{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T19:10:12Z","timestamp":1767985812235,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00262-020-02665-x","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T06:43:48Z","timestamp":1594363428000},"page":"107-121","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Selective BET-bromodomain inhibition by JQ1 suppresses dendritic cell maturation and antigen-specific T-cell responses"],"prefix":"10.1007","volume":"70","author":[{"given":"Niklas","family":"Remke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savita","family":"Bisht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Oberbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Nolting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Brossart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,10]]},"reference":[{"issue":"9","key":"2665_CR1","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1691\/ph.2018.8480","volume":"73","author":"X Shi","year":"2018","unstructured":"Shi X, Liu C, Liu B, Chen J, Wu X, Gong W (2018) JQ1: a novel potential therapeutic target. Pharmazie 73(9):491\u2013493. https:\/\/doi.org\/10.1691\/ph.2018.8480","journal-title":"Pharmazie"},{"issue":"7327","key":"2665_CR2","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/nature09504","volume":"468","author":"P Filippakopoulos","year":"2010","unstructured":"Filippakopoulos P, Qi J, Picaud S, Shen Y, Smith WB, Fedorov O, Morse EM, Keates T, Hickman TT, Felletar I, Philpott M, Munro S, McKeown MR, Wang Y, Christie AL, West N, Cameron MJ, Schwartz B, Heightman TD, La Thangue N, French CA, Wiest O, Kung AL, Knapp S, Bradner JE (2010) Selective inhibition of BET bromodomains. Nature 468(7327):1067\u20131073. https:\/\/doi.org\/10.1038\/nature09504","journal-title":"Nature"},{"issue":"6","key":"2665_CR3","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","volume":"146","author":"JE Delmore","year":"2011","unstructured":"Delmore JE, Issa GC, Lemieux ME, Rahl PB, Shi J, Jacobs HM, Kastritis E, Gilpatrick T, Paranal RM, Qi J, Chesi M, Schinzel AC, McKeown MR, Heffernan TP, Vakoc CR, Bergsagel PL, Ghobrial IM, Richardson PG, Young RA, Hahn WC, Anderson KC, Kung AL, Bradner JE, Mitsiades CS (2011) BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146(6):904\u2013917. https:\/\/doi.org\/10.1016\/j.cell.2011.08.017","journal-title":"Cell"},{"issue":"6","key":"2665_CR4","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1016\/S0002-9440(10)63049-0","volume":"159","author":"CA French","year":"2001","unstructured":"French CA, Miyoshi I, Aster JC, Kubonishi I, Kroll TG, Dal Cin P, Vargas SO, Perez-Atayde AR, Fletcher JA (2001) BRD4 bromodomain gene rearrangement in aggressive carcinoma with translocation t(15;19). Am J Pathol 159(6):1987\u20131992. https:\/\/doi.org\/10.1016\/S0002-9440(10)63049-0","journal-title":"Am J Pathol"},{"issue":"5","key":"2665_CR5","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nrd4286","volume":"13","author":"P Filippakopoulos","year":"2014","unstructured":"Filippakopoulos P, Knapp S (2014) Targeting bromodomains: epigenetic readers of lysine acetylation. Nat Rev Drug Discov 13(5):337\u2013356. https:\/\/doi.org\/10.1038\/nrd4286","journal-title":"Nat Rev Drug Discov"},{"issue":"7327","key":"2665_CR6","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/nature09589","volume":"468","author":"E Nicodeme","year":"2010","unstructured":"Nicodeme E, Jeffrey KL, Schaefer U, Beinke S, Dewell S, Chung C-W, Chandwani R, Marazzi I, Wilson P, Coste H, White J, Kirilovsky J, Rice CM, Lora JM, Prinjha RK, Lee K, Tarakhovsky A (2010) Suppression of inflammation by a synthetic histone mimic. Nature 468(7327):1119\u20131123. https:\/\/doi.org\/10.1038\/nature09589","journal-title":"Nature"},{"issue":"4","key":"2665_CR7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrc3258","volume":"12","author":"K Palucka","year":"2012","unstructured":"Palucka K, Banchereau J (2012) Cancer immunotherapy via dendritic cells. Nat Rev Cancer 12(4):265\u2013277. https:\/\/doi.org\/10.1038\/nrc3258","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"2665_CR8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nri3191","volume":"12","author":"NP Restifo","year":"2012","unstructured":"Restifo NP, Dudley ME, Rosenberg SA (2012) Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol 12(4):269\u2013281. https:\/\/doi.org\/10.1038\/nri3191","journal-title":"Nat Rev Immunol"},{"key":"2665_CR9","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.18.1.767","author":"J Banchereau","year":"2000","unstructured":"Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K (2000) Immunobiology of dendritic cells. Annu Rev Immunol. https:\/\/doi.org\/10.1146\/annurev.immunol.18.1.767","journal-title":"Annu Rev Immunol"},{"issue":"6673","key":"2665_CR10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/32588","volume":"392","author":"J Banchereau","year":"1998","unstructured":"Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392(6673):245\u2013252. https:\/\/doi.org\/10.1038\/32588","journal-title":"Nature"},{"issue":"4","key":"2665_CR11","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1084\/jem.179.4.1109","volume":"179","author":"F Sallusto","year":"1994","unstructured":"Sallusto F, Lanzavecchia A (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte\/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179(4):1109\u20131118","journal-title":"J Exp Med"},{"key":"2665_CR12","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.21.120601.141126","author":"K Takeda","year":"2003","unstructured":"Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Annu Rev Immunol. https:\/\/doi.org\/10.1146\/annurev.immunol.21.120601.141126","journal-title":"Annu Rev Immunol"},{"issue":"5687","key":"2665_CR13","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1126\/science.1099153","volume":"305","author":"MA West","year":"2004","unstructured":"West MA, Wallin RPA, Matthews SP, Svensson HG, Zaru R, Ljunggren H-G, Prescott AR, Watts C (2004) Enhanced dendritic cell antigen capture via toll-like receptor-induced actin remodeling. Science 305(5687):1153\u20131157. https:\/\/doi.org\/10.1126\/science.1099153","journal-title":"Science"},{"issue":"9","key":"2665_CR14","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.1073\/pnas.0910609107","volume":"107","author":"CD Platt","year":"2010","unstructured":"Platt CD, Ma JK, Chalouni C, Ebersold M, Bou-Reslan H, Carano RAD, Mellman I, Delamarre L (2010) Mature dendritic cells use endocytic receptors to capture and present antigens. Proc Natl Acad Sci USA 107(9):4287\u20134292. https:\/\/doi.org\/10.1073\/pnas.0910609107","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"2665_CR15","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1002\/(SICI)1521-4141(199805)28:05<1636:AID-IMMU1636>3.0.CO;2-9","volume":"28","author":"SC Knight","year":"1998","unstructured":"Knight SC, Iqball S, Roberts MS, Macatonia S, Bedford PA (1998) Transfer of antigen between dendritic cells in the stimulation of primary T cell proliferation. Eur J Immunol 28(5):1636\u20131644. https:\/\/doi.org\/10.1002\/(SICI)1521-4141(199805)28:05%3c1636:AID-IMMU1636%3e3.0.CO;2-9","journal-title":"Eur J Immunol"},{"issue":"3","key":"2665_CR16","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/S0952-7915(00)00096-0","volume":"12","author":"JJ Campbell","year":"2000","unstructured":"Campbell JJ, Butcher EC (2000) Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr Opin Immunol 12(3):336\u2013341","journal-title":"Curr Opin Immunol"},{"issue":"12","key":"2665_CR17","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/nri1246","volume":"3","author":"ML Kapsenberg","year":"2003","unstructured":"Kapsenberg ML (2003) Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 3(12):984\u2013993. https:\/\/doi.org\/10.1038\/nri1246","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2665_CR18","doi-asserted-by":"publisher","first-page":"144","DOI":"10.4049\/jimmunol.164.1.144","volume":"164","author":"LJ Appleman","year":"2000","unstructured":"Appleman LJ, Berezovskaya A, Grass I, Boussiotis VA (2000) CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression. J Immunol 164(1):144\u2013151","journal-title":"J Immunol"},{"issue":"2\u20133","key":"2665_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12026-011-8216-z","volume":"50","author":"J Cheng","year":"2011","unstructured":"Cheng J, Montecalvo A, Kane LP (2011) Regulation of NF-kappaB induction by TCR\/CD28. Immunol Res 50(2\u20133):113\u2013117. https:\/\/doi.org\/10.1007\/s12026-011-8216-z","journal-title":"Immunol Res"},{"key":"2665_CR20","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.23.021704.115839","author":"TH Watts","year":"2005","unstructured":"Watts TH (2005) TNF\/TNFR family members in costimulation of T cell responses. Annu Rev Immunol. https:\/\/doi.org\/10.1146\/annurev.immunol.23.021704.115839","journal-title":"Annu Rev Immunol"},{"issue":"12","key":"2665_CR21","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S0167-5699(99)01547-9","volume":"20","author":"P Kalinski","year":"1999","unstructured":"Kalinski P, Hilkens CM, Wierenga EA, Kapsenberg ML (1999) T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol Today 20(12):561\u2013567","journal-title":"Immunol Today"},{"issue":"2","key":"2665_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0369-8114(03)00096-8","volume":"51","author":"RM Steinman","year":"2003","unstructured":"Steinman RM (2003) The control of immunity and tolerance by dendritic cell. Pathol Biol (Paris) 51(2):59\u201360","journal-title":"Pathol Biol (Paris)"},{"key":"2665_CR23","doi-asserted-by":"publisher","DOI":"10.3791\/773","author":"MP Matheu","year":"2008","unstructured":"Matheu MP, Sen D, Cahalan MD, Parker I (2008) Generation of bone marrow derived murine dendritic cells for use in 2-photon imaging. J Vis Exp. https:\/\/doi.org\/10.3791\/773","journal-title":"J Vis Exp"},{"issue":"7","key":"2665_CR24","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1182\/blood-2013-03-484642","volume":"122","author":"A Heine","year":"2013","unstructured":"Heine A, Held SAE, Daecke SN, Wallner S, Yajnanarayana SP, Kurts C, Wolf D, Brossart P (2013) The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo. Blood 122(7):1192\u20131202. https:\/\/doi.org\/10.1182\/blood-2013-03-484642","journal-title":"Blood"},{"issue":"12","key":"2665_CR25","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1182\/blood-2004-12-4709","volume":"106","author":"S Appel","year":"2005","unstructured":"Appel S, Mirakaj V, Bringmann A, Weck MM, Gr\u00fcnebach F, Brossart P (2005) PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways. Blood 106(12):3888\u20133894. https:\/\/doi.org\/10.1182\/blood-2004-12-4709","journal-title":"Blood"},{"issue":"8","key":"2665_CR26","doi-asserted-by":"publisher","first-page":"4264","DOI":"10.1182\/blood-2006-10-051375","volume":"111","author":"MM Weck","year":"2008","unstructured":"Weck MM, Appel S, Werth D, Sinzger C, Bringmann A, Gr\u00fcnebach F, Brossart P (2008) hDectin-1 is involved in uptake and cross-presentation of cellular antigens. Blood 111(8):4264\u20134272. https:\/\/doi.org\/10.1182\/blood-2006-10-051375","journal-title":"Blood"},{"key":"2665_CR27","doi-asserted-by":"publisher","DOI":"10.1017\/s1462399411001992","author":"S Muller","year":"2011","unstructured":"Muller S, Filippakopoulos P, Knapp S (2011) Bromodomains as therapeutic targets. Expert Rev Mol Med. https:\/\/doi.org\/10.1017\/s1462399411001992","journal-title":"Expert Rev Mol Med"},{"issue":"4","key":"2665_CR28","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll DM (2012) The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 12(4):252\u2013264. https:\/\/doi.org\/10.1038\/nrc3239","journal-title":"Nat Rev Cancer"},{"issue":"17","key":"2665_CR29","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1182\/blood-2014-08-598037","volume":"125","author":"Y Sun","year":"2015","unstructured":"Sun Y, Wang Y, Toubai T, Oravecz-Wilson K, Liu C, Mathewson N, Wu J, Rossi C, Cummings E, Wu D, Wang S, Reddy P (2015) BET bromodomain inhibition suppresses graft-versus-host disease after allogeneic bone marrow transplantation in mice. Blood 125(17):2724\u20132728. https:\/\/doi.org\/10.1182\/blood-2014-08-598037","journal-title":"Blood"},{"key":"2665_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2016.09.010","author":"R Schilderink","year":"2016","unstructured":"Schilderink R, Bell M, Reginato E, Patten C, Rioja I, Hilbers FW, Kabala PA, Reedquist KA, Tough DF, Tak PP, Prinjha RK, de Jonge WJ (2016) BET bromodomain inhibition reduces maturation and enhances tolerogenic properties of human and mouse dendritic cells. Mol Immunol. https:\/\/doi.org\/10.1016\/j.molimm.2016.09.010","journal-title":"Mol Immunol"},{"issue":"7","key":"2665_CR31","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.4049\/jimmunol.1401635","volume":"194","author":"PA Toniolo","year":"2015","unstructured":"Toniolo PA, Liu S, Yeh JE, Moraes-Vieira PM, Walker SR, Vafaizadeh V, Barbuto JAM, Frank DA (2015) Inhibiting STAT5 by the BET bromodomain inhibitor JQ1 disrupts human dendritic cell maturation. J Immunol 194(7):3180\u20133190. https:\/\/doi.org\/10.4049\/jimmunol.1401635","journal-title":"J Immunol"},{"issue":"7","key":"2665_CR32","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.4049\/jimmunol.1202838","volume":"190","author":"AC Belkina","year":"2013","unstructured":"Belkina AC, Nikolajczyk BS, Denis GV (2013) BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses. J Immunol 190(7):3670\u20133678. https:\/\/doi.org\/10.4049\/jimmunol.1202838","journal-title":"J Immunol"},{"issue":"7","key":"2665_CR33","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1177\/0022034514534261","volume":"93","author":"S Meng","year":"2014","unstructured":"Meng S, Zhang L, Tang Y, Tu Q, Zheng L, Yu L, Murray D, Cheng J, Kim SH, Zhou X, Chen J (2014) BET inhibitor JQ1 blocks inflammation and bone destruction. J Dent Res 93(7):657\u2013662. https:\/\/doi.org\/10.1177\/0022034514534261","journal-title":"J Dent Res"},{"issue":"6","key":"2665_CR34","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.3892\/etm.2015.2789","volume":"10","author":"Y Sun","year":"2015","unstructured":"Sun Y, Huang J, Song K (2015) BET protein inhibition mitigates acute myocardial infarction damage in rats via the TLR4\/TRAF6\/NF-\u03baB pathway. Exp Ther Med 10(6):2319\u20132324. https:\/\/doi.org\/10.3892\/etm.2015.2789","journal-title":"Exp Ther Med"},{"issue":"3","key":"2665_CR35","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1128\/MCB.01353-13","volume":"34","author":"S Wienerroither","year":"2014","unstructured":"Wienerroither S, Rauch I, Rosebrock F, Jamieson AM, Bradner J, Muhar M, Zuber J, Muller M, Decker T (2014) Regulation of NO synthesis, local inflammation, and innate immunity to pathogens by BET family proteins. Mol Cell Biol 34(3):415\u2013427. https:\/\/doi.org\/10.1128\/MCB.01353-13","journal-title":"Mol Cell Biol"},{"issue":"5","key":"2665_CR36","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1158\/1535-7163.MCT-13-0341","volume":"13","author":"S Liu","year":"2014","unstructured":"Liu S, Walker SR, Nelson EA, Cerulli R, Xiang M, Toniolo PA, Qi J, Stone RM, Wadleigh M, Bradner JE, Frank DA (2014) Targeting STAT5 in hematologic malignancies through inhibition of the bromodomain and extra-terminal (BET) bromodomain protein BRD2. Mol Cancer Ther 13(5):1194\u20131205. https:\/\/doi.org\/10.1158\/1535-7163.MCT-13-0341","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"2665_CR37","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1189\/jlb.71.3.511","volume":"71","author":"A Lehtonen","year":"2002","unstructured":"Lehtonen A, Matikainen S, Miettinen M, Julkunen I (2002) Granulocyte-macrophage colony-stimulating factor (GM-CSF)-induced STAT5 activation and target-gene expression during human monocyte\/macrophage differentiation. J Leukoc Biol 71(3):511\u2013519","journal-title":"J Leukoc Biol"},{"issue":"6","key":"2665_CR38","doi-asserted-by":"publisher","first-page":"e0128897","DOI":"10.1371\/journal.pone.0128897","volume":"10","author":"A Heine","year":"2015","unstructured":"Heine A, Held SAE, Daecke SN, Riethausen K, Kotthoff P, Flores C, Kurts C, Brossart P (2015) The VEGF-receptor inhibitor axitinib impairs dendritic cell phenotype and function. PLoS ONE 10(6):e0128897. https:\/\/doi.org\/10.1371\/journal.pone.0128897","journal-title":"PLoS ONE"},{"issue":"6","key":"2665_CR39","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.4049\/jimmunol.166.6.3837","volume":"166","author":"JF Arrighi","year":"2001","unstructured":"Arrighi JF, Rebsamen M, Rousset F, Kindler V, Hauser C (2001) A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers. J Immunol 166(6):3837\u20133845. https:\/\/doi.org\/10.4049\/jimmunol.166.6.3837","journal-title":"J Immunol"},{"key":"2665_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-018-0258-7","author":"H Wang","year":"2018","unstructured":"Wang H, Huang W, Liang M, Shi Y, Zhang C, Li Q, Liu M, Shou Y, Yin H, Zhu X, Sun X, Hu Y, Shen Z (2018) (+)-JQ1 attenuated LPS-induced microglial inflammation via MAPK\/NF\u03baB signaling. Cell Biosci. https:\/\/doi.org\/10.1186\/s13578-018-0258-7","journal-title":"Cell Biosci"},{"issue":"9","key":"2665_CR41","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1002\/(SICI)1521-4141(199809)28:09<2760:AID-IMMU2760>3.0.CO;2-N","volume":"28","author":"F Sallusto","year":"1998","unstructured":"Sallusto F, Schaerli P, Loetscher P, Schaniel C, Lenig D, Mackay CR, Qin S, Lanzavecchia A (1998) Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol 28(9):2760\u20132769. https:\/\/doi.org\/10.1002\/(SICI)1521-4141(199809)28:09%3c2760:AID-IMMU2760%3e3.0.CO;2-N","journal-title":"Eur J Immunol"},{"key":"2665_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2015.00001","author":"Z Liu","year":"2015","unstructured":"Liu Z, Roche PA (2015) Macropinocytosis in phagocytes: regulation of MHC class-II-restricted antigen presentation in dendritic cells. Front Physiol. https:\/\/doi.org\/10.3389\/fphys.2015.00001","journal-title":"Front Physiol"},{"issue":"11","key":"2665_CR43","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1084\/jem.20130376","volume":"210","author":"DA Mele","year":"2013","unstructured":"Mele DA, Salmeron A, Ghosh S, Huang H-R, Bryant BM, Lora JM (2013) BET bromodomain inhibition suppresses TH17-mediated pathology. J Exp Med 210(11):2181\u20132190. https:\/\/doi.org\/10.1084\/jem.20130376","journal-title":"J Exp Med"},{"issue":"1\u20132","key":"2665_CR44","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/S0041-1345(96)00532-5","volume":"29","author":"F Fu","year":"1997","unstructured":"Fu F, Li Y, Qian S, Lu L, Chambers FD, Starzl TE, Fung JJ, Thomson AW (1997) Costimulatory molecule-deficient dendritic cell progenitors induce T cell hyporesponsiveness in vitro and prolong the survival of vascularized cardiac allografts. Transpl Proc 29(1\u20132):1310","journal-title":"Transpl Proc"},{"issue":"7","key":"2665_CR45","doi-asserted-by":"publisher","first-page":"294","DOI":"10.4049\/immunohorizons.1900037","volume":"3","author":"P Georgiev","year":"2019","unstructured":"Georgiev P, Wang Y, Muise ES, Bandi ML, Blumenschein W, Sathe M, Pinheiro EM, Shumway SD (2019) BET bromodomain inhibition suppresses human T cell function. Immunohorizons 3(7):294\u2013305. https:\/\/doi.org\/10.4049\/immunohorizons.1900037","journal-title":"Immunohorizons"},{"issue":"4","key":"2665_CR46","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1128\/MCB.18.4.1996","volume":"18","author":"MH Kaplan","year":"1998","unstructured":"Kaplan MH, Daniel C, Schindler U, Grusby MJ (1998) Stat proteins control lymphocyte proliferation by regulating p27Kip1 expression. Mol Cell Biol 18(4):1996\u20132003","journal-title":"Mol Cell Biol"},{"issue":"9","key":"2665_CR47","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/j.celrep.2017.02.011","volume":"18","author":"SJ Hogg","year":"2017","unstructured":"Hogg SJ, Vervoort SJ, Deswal S, Ott CJ, Li J, Cluse LA, Beavis PA, Darcy PK, Martin BP, Spencer A, Traunbauer AK, Sadovnik I, Bauer K, Valent P, Bradner JE, Zuber J, Shortt J, Johnstone RW (2017) BET-bromodomain inhibitors engage the host immune system and regulate expression of the immune checkpoint ligand PD-L1. Cell Rep 18(9):2162\u20132174. https:\/\/doi.org\/10.1016\/j.celrep.2017.02.011","journal-title":"Cell Rep"},{"issue":"10","key":"2665_CR48","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1002\/(SICI)1521-4141(199910)29:10<3245:AID-IMMU3245>3.0.CO;2-X","volume":"29","author":"M Salio","year":"1999","unstructured":"Salio M, Cella M, Suter M, Lanzavecchia A (1999) Inhibition of dendritic cell maturation by herpes simplex virus. Eur J Immunol 29(10):3245\u20133253. https:\/\/doi.org\/10.1002\/(SICI)1521-4141(199910)29:10%3c3245:AID-IMMU3245%3e3.0.CO;2-X","journal-title":"Eur J Immunol"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-020-02665-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-020-02665-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-020-02665-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T05:39:00Z","timestamp":1667367540000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-020-02665-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,10]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["2665"],"URL":"https:\/\/doi.org\/10.1007\/s00262-020-02665-x","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,10]]},"assertion":[{"value":"17 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Animal experiments described here comply with Directive 2010\/63\/EU and were approved by the government of the state of North Rhine-Westphalia. Mice were maintained according to the guidelines of the Federation of European Laboratory Animal Science Associations (FELASA). The studies were approved by the EC (131\/11, 173\/09).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The strains <i>C57BL\/6<\/i>-<i>Tg(TcraTcrb)1100Mjb\/Crl<\/i> (OT I Mouse) and <i>C57BL\/6<\/i>-<i>Tg(TcraTcrb)425Cbn\/Crl<\/i> (OT II Mouse) were generously provided by J.G. van den Boorn (Dept. of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany). Each strain used in the study was originally supplied by Charles River.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal source"}}]}}